Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate Safety and Effectiveness of Endoscopic Hemostactic Powder, 'Nexpowder' for Hemostatic Treatments of Nonvariceal, Upper Gastrointestinal Bleeding

NCT04124588 is registered in ClinicalTrials.gov with Next Biomedical Co., Ltd. as lead sponsor.

NCT NCT04124588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04124588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate Safety and Effectiveness of Endoscopic Hemostactic Powder, 'Nexpowder' for Hemostatic Treatments of Nonvariceal, Upper Gastrointestinal Bleeding
Lead sponsor
Next Biomedical Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
November 11, 2021
Enrollment
348 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nonvariceal upper gastrointestinal bleeding